Cisplatin
Cisplatin
Products
Contact Us

We are here to help in anything you need. Please use our online system or send an email to .

Cisplatin

Inquiry

Catalog NumberPR14913338

CAS Number14913-33-8

CategoryAnticancer

Cisplatin
Synonyms trans-Dichlorodiamineplatinum(II); azane;dichloroplatinum; Platinum, diamminedichloro-, (SP-4-1)-
IUPAC Name azane;dichloroplatinum
Molecular Weight 300.05
Molecular Formula Cl2H6N2Pt
InChI LXZZYRPGZAFOLE-UHFFFAOYSA-L
InChI Key InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
Drug Categories Antineoplastic Agents; Antineoplastic and Immunomodulating Agents; BCRP/ABCG2 Substrates; Cardiotoxic antineoplastic agents; Chlorine Compounds; Cholinesterase Inhibitors; Compounds used in a research, industrial, or household setting; Cross-Linking Reagents; Cytochrome P-450 CYP2B6 Inhibitors; Cytochrome P-450 CYP2B6 Inhibitors (strength unknown); Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors (strength unknown); Cytochrome P-450 Enzyme Inhibitors; Drugs that are Mainly Renally Excreted; Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index; Immunosuppressive Agents; Indicators and Reagents; Laboratory Chemicals; Myelosuppressive Agents; Narrow Therapeutic Index Drugs; Nephrotoxic agents; Nitrogen Compounds; OCT2 Inhibitors; OCT2 Substrates; OCT2 Substrates with a Narrow Therapeutic Index; Platinum Compounds; Radiation-Sensitizing Agents
Drug Interactions Abacavir-Abacavir may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Abatacept-The risk or severity of adverse effects can be increased when Cisplatin is combined with Abatacept.
Abciximab-The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin.
Acebutolol-Cisplatin may increase the bradycardic activities of Acebutolol.
Aceclofenac-Aceclofenac may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Isomeric SMILES N.N.Cl[Pt]Cl
Therapeutic Category Anticancer
Type Small Molecule

It should be noted that our service is only used for research, not for clinical use.